Search Results

<< Back to podcast list Strategic Partner(s) Yao Lu (Jackie) About Yao Lu (Jackie) "Jackie is a Ph.D. small molecules for their pre-clinical efficacy and to support the design of novel therapeutics. " Yao Lu (Jackie) on the web Monash University Georgina Sweet Fellowship Authorea Dr.

During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash Cam Sinh Lu on the web LinkedIn Dr.

Bernadyn, Mariane Nascimento, Xinyi Lu, Pauline L. Pan, Michael Holinstat and Gregory G.

CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program HERE < Back to Full Agenda Complimentary Lunch

Lunch and farewell Date & Time Saturday, November 4th / 12:30 PM Previous Event Next Event Great Lakes

GPCR Retreat Program < Back to schedule Lunch 1 Date & Time Friday, November 3rd / 12:10 PM !

Lukas Grätz About Dr. Lukas Grätz "After a BSc in biology and a MSc in bioinformatics, I have been working in David Gloriam's Lukas Grätz on the web Karolinska Institutet ResearchGate PubMed Dr.

Steroid Hormone Receptors and Hearing and Balance Receptors Jinpeng Sun Read More 2:00 PM Complimentary Lunch Mihaylov · Anne Bormann Read More 1:00 PM Complimentary Lunch Read More 2:00 PM Posters Caroline Formstone periphery Cheng-Chih Hsiao · Anastasia Georgiadi · Douglas Tilley Read More 12:30 PM Complimentary Lunch

David Hodson Topics Covered: LUXendin probes for GLP-1R labeling across imaging modalities daLUXendin

Frederik Leeb-Lundberg (1984) Dr. Robert Lefkowitz (1973) Dr. Lee Limbird (1973) Dr.

p38 signaling responses we are studying how atypical p38 controls the onset and pathogenesis of acute lung

AM Coffee Break 10/23/2024 12:00 PM Session I 10/23/2024 01:00 PM Plenary Lecture 10/23/2024 2:00 PM Lunch AM Session IV 10/24/2024 12:00 PM Plenary Lecture II 10/24/2024 1:00 PM Posters 10/24/2024 2:00 PM Lunch Session VII 10/25/2024 12:00 PM Plenary Lecture III 10/25/2024 1:00 PM Session VIII 10/25/2024 2:00 PM Lunch

examine the assay principle, validation strategy, and performance across reference antagonists and agonis Lucía degenerative, metabolic, immunological… around a third of the drugs in clinical use are GPCR ligands Lucía

Arrestin Recruitment Detect β-arrestin recruitment with TR-FRET and luminescence assays tailored for

LUXendin Family Red and far-red fluorescent GLP-1R antagonists derived from Exendin4(9–39). He is a principal architect of the LUXendin and daLUXendin probe families. Dr.

CELSR1 is reactivated in luminal-type ductal carcinomas. Notably, our pilot data from luminal-type breast cancer cell lines representative of breast carcinomas specific hypothesis that biased expression of CELSR1 isoforms will predict invasive potential of a luminal tumour invasive mechanism (b) quantify CELSR1 isoform expression (mRNA and protein) within patient luminal

Annette Gilchrist About this episode Originally, Annette wanted to be a medical doctor but as luck has

Monserrat Avila Zozaya "My doctoral research was focused on investigating the cellular effects of missense lung

Monserrat Avila Zozaya "My doctoral research was focused on investigating the cellular effects of missense lung Van Meir pursued postdoctoral work at the Ludwig Institute for Cancer Research in San Diego and joined

project, licensed to AstraZeneca (Saphnelo™ Anifrolumab) that has just received FDA approval for systemic lupus

Kussmaulallee 12, 91054 Erlangen, Germany 2 Developmental Genetics, Max-Planck-Institute for Heart and Lung Research, Ludwigstrasse 43, 61231 Bad Nauheim, Germany 3 Department of Developmental Biology, Washington Immunoblots on wild-type and Adgrb1 exon 2-deleted mice, reverse transcription PCR and promoter-luciferase We previously demonstrated that kidney-specific Adgrf5/Gpr116 knockout causes luminal membrane accumulation James Bridges at National Jewish Health in Denver, CO researching molecular mechanisms of lung injury

adapted for the human aGPCRs CD97/ADGRE5 and Latrophilin/ADGRL3 and tested in HEK293T cells using a luciferase

development. have been engaged in GPCR cellular and clinical pharmacology as scientist or PI in neonatal lupus

From Curiosity to Collaboration “We decided to evaluate the multiplexing methods... and found this Luminex assay.” – Tom Sakmar After exploring several screening techniques, the lab adopted the Luminex bead-based

Alexander Hauser , and Luise Wagner .

Druey at NIAID/NIH, where I characterized the role of RGS4 and RGS5 in airway hyperresponsiveness and lung fascinated by the multitude of processes that are regulated/dysregulated by GPCRs and RGS proteins in the lungs

In 2018 he joined the University of Copenhagen, where he has received an ERC Starting Grant, Lundbeck

Washington University, the NIH and UCLA, he pursued his postdoctoral studies with Allan Bernstein at the Lunenfeld

Lamichhane Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer Stefan Diethelm , Luboš